TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.
Sommariva M, De Cecco L, De Cesare M, Sfondrini L, Ménard S, Melani C, Delia D, Zaffaroni N, Pratesi G, Uva V, Tagliabue E, Balsari A.
Sommariva M, et al. Among authors: de cecco l, de cesare m.
Cancer Res. 2011 Oct 15;71(20):6382-90. doi: 10.1158/0008-5472.CAN-11-1285. Epub 2011 Aug 30.
Cancer Res. 2011.
PMID: 21878529